glp 1 agonist retatrutide Understanding the Next-Gen Weight Loss Drug: (GLP-1, GIP, and Glucagon Receptor Agonist) Retatrutide Triple Agonist Peptide |

Summary report of inconsistent advice on blood pressure targets (NG17 update)

They also help explain why only about one-third to half of people remain on GLP-1s after a year, with cost likely playing a role as well

For patients who have not yet started treatment and want to understand whether a medical weight loss program might be suitable, speaking with an AHPRA-registered GP through a telehealth consultation can help clarify your options and eligibility.

October 1, 2025: Most Ozempic Users Stop Taking It Within First Year of Starting, Study Finds A new study has found that most people who take Ozempic discontinue treatment within 1 year

L-Carnitine, as we have said, is widely used by sportsmen and women , and sometimes, together with a balanced diet for this ingredient, it can be supplied as a dietary supplement as an energy input for specific activities